Search Results
Search results for "Helen Su"
Results found for "Helen Su"
- Dr. GPCR Univeristy for Developing Countries | Dr. GPCR Ecosystem
Access for All: Supporting Scientists Worldwide Access shouldnât depend on geography. To support the global GPCR community, Dr. who live and work in developing countries, as defined by international economic classifications. 2ïžâŁ Submit
- Dr. Timo De Groof | Dr. GPCR Ecosystem
2019, he completed his Ph.D. in the Medicinal Chemistry group at VU University Amsterdam under the supervision
- Celtarys Research | Dr. GPCR Ecosystem
custom development services, where we tackle challenging targets and synthesize probes with the most suitable Research develops high-quality, fluorescently labeled ligands and innovative chemical biology tools to support âWeâre excited to support the GPCR community with tools that deliver clarity, sensitivity, and speed, Contact Celtarys Research First name* Last name Email* Write a message Submit Get in Touch Address Avda
- Tuning GPCR System Sensitivity: Revealing True Drug Activity Through Functional Volume Control | Dr. GPCR Ecosystem
cell-based assays spanning basic research through therapeutic discovery, optimization, and regulatory submission
- Chloe Hicks | Dr. GPCR Ecosystem
These previous endeavors involved exploring the effect of subcellular location on the signaling profile
- Dr. Andrew Tobin | Dr. GPCR Ecosystem
In this Andrew runs a research laboratory of around 15 staff supported by basic research grants investigating
- Anita Nivedha: Computational Dynamics of Ligand Bias in GPCR Signaling | Dr. GPCR Ecosystem
Subtype Selectivity Emerges from Subtle Structural Differences Even closely related receptor subtypes also not surprised. Some GPCR families contain closely related subtypes. Ligands may bind one subtype strongly but another weakly. Subscribe to the Dr. GPCR podcast so you never miss a discussion.
- Dr. Simone Prömel & Dr. Ines Liebscher | Dr. GPCR Ecosystem
During her medical studies in Leipzig, she had her first encounter with an orphan GPCR as the subject
- Lin and Ball: GPCR Antibody Characterization and the Recombinant Shift | Dr. GPCR Ecosystem
Chia-Yi Lin is the head of international sales, marketing, technical support, and logistics at GeneTex reproducibility Researcher-company collaboration as an active ingredient in antibody quality - not a support single rabbit is immunized, the choice of immunogen has already determined whether a GPCR antibody can succeed Ball recounts his company's president going pale when the subject came up: every commercial antibody
- Dylan Eiger | Dr. GPCR Ecosystem
Sudarshan Rajagopal, a former postdoctoral fellow of Dr. Robert J. Lefkowitz . GPCRs, specifically, the role of differential receptor phosphorylation (phosphorylation barcodes) and subcellular After finishing his MD/Ph.D., Dylan plans to complete his residency training in Internal Medicine and subsequently
- Dr. Demet Araç | Dr. GPCR Ecosystem
GPCR AI Summary AI-generated content may be inaccurate or misleading. Always check for accuracy. Summary Personal Backgrounds and GPCR Interest Yamina and Demet had a discussion about their personal Demet, who had studied various subjects including chemistry, physics, biology, and math, shared his interest project since 2013, screening about 20 adhesion GPCRs, with the Latrophilin 3 construct proving most successful
- From Rare Earth Probes to Internalization Assays: The pHSense Story with Dr. Eric Trinquet | Dr. GPCR Ecosystem
Youâll hear what truly makes a reagent successfulâand why academicâindustry collaborations are essential
- Joseph Kim: Structural Biology and Drug Discovery at GPCRs | Dr. GPCR Ecosystem
Supportive collaborative environments accelerate scientific progress. Joseph Kim: Sure. Thereâs evidence suggesting that it plays roles in feeding behavior and analgesia , somewhat similar Some studies also suggest that the galanin receptors may interact with the ÎŒ-opioid receptor. lab where people were supportive and willing to teach.
- GPCR University Group Package | Dr. GPCR Ecosystem
If fewer than five members are submitted: âą Memberships wonât be activated. âą Youâll receive a 50% refund to cover processing costs. đ Please double-check your team list before submitting to avoid delays. GPCR Ecosystem account . 2 â Submit Your Team Details Provide names, emails, and organization information
- Dr. Nicholas Holliday | Dr. GPCR Ecosystem
undergraduate degree at the University of Cambridge, Nick carried out his Ph.D. at Kingâs College London, supported It was these studies and subsequent postdoctoral work that led to Nick's interest in peptide messengers
- Dr. Benjamin Myers | Dr. GPCR Ecosystem
signaling pathways that operate within the primary cilium, a tiny antenna-shaped structure at the cell surface
- Alexander Hauser: GPCR Pharmacogenomics and Precision Psychiatry | Dr. GPCR Ecosystem
culture makes it structurally possible 31:45 - Mentoring philosophy - teaching through mistakes and sustaining
- Dr. Ilana Kotliar | Dr. GPCR Ecosystem
Ilana graduated Summa cum laude from Cornell University, where she studied Chemistry and Chemical Biology
- Dr. Josh Pottel | Dr. GPCR Ecosystem
(MFI): a reliable, self-sustaining computational chemistry service provider, developing its own software I am now combining my training as a chemist and as an entrepreneur to grow a sustainable service and
- Introduction-to-GLP1-pharmacology | Dr. GPCR Ecosystem
The discussion will examine how GLP-1 regulates insulin secretion, suppresses glucagon release, slows
- Silvio Gutkind: When GPCRs Drive Cancer | Dr. GPCR Ecosystem
expression â a receptor in the wrong place at the wrong time, paired with autocrine or paracrine ligand â is sufficient Gutkind's most cited papers came from results that directly contradicted the textbook: ÎČÎł subunits (not
- Receptor Signaling Bias: A Valuable and Accessible Property of New Drug Candidates | Dr. GPCR Ecosystem
cell-based assays spanning basic research through therapeutic discovery, optimization, and regulatory submission
- YC-BioTech | Dr. GPCR Ecosystem
biotechsâtypically preclinical through IND-enablingâwho need strategic clarity and hands-on discovery support Letâs talk about how I support GPCR discovery, pharmacology strategy, and cross-functional execution
- Graciela Pineyro: Resilience, Lab Life, and the Zoom Effect | Dr. GPCR Ecosystem
planning in self-contained blocks, flatter meeting dynamics, planned reflection time â may deserve to survive Pineyro notes she isn't sure why â something about speaking from home, something about reduced interpersonal Some pandemic-era practices deserve to survive. Not because the pandemic was good for science, but because normal lab life had quietly suppressed some Episode Timeline Timestamps were generated using AI for readability. 00:00 Introduction and 2020 Summit
- Dr. Françoise Bachelerie | Dr. GPCR Ecosystem
one that reviewed the standard nomenclature for chemokine receptors that are categorized into a large subgroup of G proteinâcoupled (GPCR) leukocyte chemotactic receptors (including CXCR4), and a smaller subgroup
- Exploring Career Paths in GPCR Research with Dr. Jacek MokrosiĆski | Dr. GPCR Ecosystem
He then moved to Denmark, where he trained at the University of Copenhagen under supervision of Professor GPCR AI Summary AI-generated content may be inaccurate or misleading. Always check for accuracy. Summary Embracing Cultural Differences and Collaboration Yamina and Jacek shared their experiences with He also underscored the role of the people around him, expressing gratitude for their guidance and support
- Foundry for GPCR Organizations | Dr. GPCR Ecosystem
Expert support, trusted CROs, and ready-to-use tools to accelerate GPCR drug discovery, reduce risk, Book a Strategy Call â Our Core Support Areas Discovery Consulting & Strategy Expert guidance to de-risk
- Dr. Ralf Jockers | Dr. GPCR Ecosystem
International Research Network (IRN) i-GPCRnet of the CNRS, is chair of IUPHAR « Melatonin receptor » sub-committee
- Dr. Prasenjit Saha | Dr. GPCR Ecosystem
attention as they have the potential to fine-tune cellular responses with greater selectivity among the subtypes
- Ross Cheloha: Nanobody-GPCR Conjugates and the Engineering of Receptor Selectivity | Dr. GPCR Ecosystem
And can selectivity for one receptor subtype be engineered without redesigning the ligand from scratch 10,000-fold, and how the selectivity of the nanobody - not the ligand - is what engineers receptor subtype have been using this distinction all along: two natural ligands for the same receptor already show subtly The working model is that the nanobody anchors the conjugate at the receptor surface, positioning the Attaching a short PTH fragment to a PTHR1-selective nanobody produces a ligand selective for that subtype

























